Patent intelligence · US
US 7001919
Forms of pravastatin sodium
Forms of pravastatin sodium
Patent details — US 7001919
- Jurisdiction
- US
- Status
- expired
- Grant date
- Feb 21, 2006
- Expiration
- Feb 16, 2026
- Applicant
- Teva Gyogyszergyar Reszvenytarsasag
- Claims
- 168
- CPC classes
- A61K, A61K31/335, A61P, A61P3/06
Quick answer
US 7001919 (Forms of pravastatin sodium) is held by Teva Gyogyszergyar Reszvenytarsasag. Status: expired. Granted Feb 21, 2006. Expires Feb 16, 2026 (0 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- Teva Gyogyszergyar Reszvenytarsasag
- Grant date
- Expiration
- Claims
- 168
- CPC classes
- A61K, A61K31/335, A61P, A61P3/06, A61P9/10
More from Teva Gyogyszergyar Reszvenytarsasag
Related pharmaceutical patents in our USPTO index.
-
US 12310929
Use of rasagiline for the treatment of restless legs syndrome
granted -
US 12258401
Anti-CD47 combination therapy
granted -
US 12157729
Solid state forms of Belumosudil and Belumosudil salts
granted -
US 12139528
Treating refractory migraine
granted -
US 12091388
Solid state forms of Reproxalap
granted -
US 11826322
Pre-filled syringe
granted -
US 11813359
Sustained release olanzapine formulations
granted -
US 11773083
Solid state forms of Belumosudil and Belumosudil salts
granted
Frequently asked questions
What is US patent 7001919?
US 7001919 (Forms of pravastatin sodium) is held by Teva Gyogyszergyar Reszvenytarsasag. Status: expired. Granted Feb 21, 2006. Expires Feb 16, 2026 (0 years remaining) — relevant for patent-cliff and LOE planning.
Who owns US 7001919?
Teva Gyogyszergyar Reszvenytarsasag is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 454 pharmaceutical patents for this assignee.
When does US 7001919 expire?
Our index shows an expiration date of Feb 16, 2026 (0 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.